Results 111 to 120 of about 23,073,058 (182)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis

, 2015
the research work was conducted for the pharmacoeconomic evaluation and optimization of fluid therapy for patients, suffering from peritonitis disease. Reamberin, Ringer's solution, Plasma-Lyte and Sterofundin drugs were compared during the analysis.
M. M. Murashko, R. I. Yagudina
core  

Analysis of pharmacoeconomic parameters of therapy of corneal conjunctival xerosis with the use of immunomodulator and antioxidant [PDF]

, 2017
The results of pharmacoeconomic analysis of complex therapy regimens for transient corneal-conjunctival xerosis (CCX) are presented in the study. The advantage of the scheme with the use of an immunomodulator and an antioxidant with standard CCX therapy ...
Жданович, И. В., Савченко, М. Д., Rudakova, G. V., Razgulin, A. S., Zhdanovich, I. V., Столярова, В. В., Stolyarova, V. V., Разгулин, А. С., Рудакова, Г. В., Savchenko, M. D., Gerard, M. A., Жерар, М. А.   +11 more
core  

Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study. [PDF]

J Clin Med, 2022
Rosati A, Conti P, Berto P, Molinaro S, Baldini F, Egan CG, Panichi V, Tuscany Study Group for Ferric Carboxymaltose.   +7 more
europepmc   +1 more source

Pharmacoeconomic Fellowships: The Need for Outcome Measures

Pharmacoeconomic fellowship programmes have been in existence for more than 10 years, but their effectiveness has not been evaluated. The aim of this project was to construct a framework to examine the potential outcome measures for pharmacoeconomic ...
Vittorio Maio, Tammy K. Girts, Jennifer H. Lofland, David B. Nash   +3 more
core  

Pharmacoeconomic analysis of alogliptin use in the treatment of type 2 diabetes [PDF]

, 2018
Aim of the study: Determine the validity of alogliptin choice in comparison with other DPP-4 inhibitors, available in Russia (saxagliptin, linagliptin, vildagliptin, sitagliptin) for add-on treatment in patients with inadequate glycemic control on ...
S. V. Nedogoda, I. N. Sorokina, A. S. Salasiuk, V. O. Smirnov   +3 more
core  

Pharmacoeconomic Analysis of Heartworm Preventive Compliance and Revenue in Veterinary Practices in the United States. [PDF]

Front Vet Sci, 2021
Mwacalimba K, Amodie D, Swisher L, Moldavchuk M, Brennan C, Walther C, Bowman K.   +6 more
europepmc   +1 more source

Pharmacoeconomic analysis of progestogen preparations for threatened abortion treatment in Ukraine [PDF]

, 2013
Objectives: Comparative evaluation the cost effectiveness of threatened abortion treatment by two regimens: oxyprogesteronicaproas and dydrogesterone in Ukraine.
Tkachоva, O., Iakovlieva, L., Matyashova, N., Mishchenko, O.   +3 more
core  

Pharmacoeconomic analysis of biologics and methotrexate for rheumatoid arthritis from the standpoint of the number needed to treat concept under the Japanese health insurance system. [PDF]

Cost Eff Resour Alloc, 2022
Harigane K, Mochida Y, Shimazaki T, Kobayashi N, Inaba Y.   +4 more
europepmc   +1 more source

CLINICAL AND PHARMACOECONOMIC ANALYSIS OF CARBAPENEMS (MEROPENEM, IMIPENEM AND DORIPENEM) IN NOSOCOMIAL PNEUMONIA TREATMENT

, 2015
the article presents the results of a retrospective study conducted in the period from 2008 to 2011 in Moscow’s hospitals. The aim of the study was to compare the clinical and pharmacoeconomical efficacy of carbapenems in nosocomial pneumonia treatment ...
S. K. Zyryanov, I. I. Shteynberg, Yu. B. Belousov   +2 more
core  

COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS

Фармакоэкономика, 2015
Annually, all over the world there are 300 000 new patients with leukemia (approximately 3% of all oncology diseases), and mortality due to leukemia is 220 000 patients.
R. I. Yagudina, A. Yu. Kulikov, I. A. Komarov   +2 more
doaj